Dr. Emily Marie Ferraro, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 814-590-1090 |
Dr. Henry Spencer Eden, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Building 13 Room 3n17 Msc #5766, Nih, Bethesda, MD 20892 Phone: 301-435-1953 Fax: 301-421-0010 |
Nicole Skaggs, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 301-295-4000 |
Eric Robert Kuhn, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4494 Palmer Rd N, Bethesda, MD 20814 Phone: 301-295-4000 |
Melissa J Walsh, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4494 Palmer Rd N, Bethesda, MD 20814 Phone: 301-295-0196 |
Mr. David Kerling Jr., MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4000 |
Alexis Rae Mango, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: Walter Reed National Military Medical Center Psychiatry, 8901 Wisconsin Avenue, Bethesda, MD 20889 Phone: 301-295-4503 |
Hana Kiyo Yokoi, General Practice Medicare: Not Enrolled in Medicare Practice Location: Ncc0walter Reed National Military Medical Center, Bethesda, MD 20889 Phone: 301-295-0655 |
Arjun Patel, MD General Practice Medicare: Medicare Enrolled Practice Location: 4494 North Palmer Road, Bethesda, MD 20889 Phone: 301-295-5165 |
Kevin Ung Sei, General Practice Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-400-2838 |
Dr. Rebecca Lee, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4494 North Palmer Road Anesthesiology Department, Bethesda, MD 20889 Phone: 301-295-4455 |
Devin Jagow, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 4494 Palmer Rd N, Bethesda, MD 20814 Phone: 301-295-4584 |
Dr. Graham Christian Ellis, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889 Phone: 301-295-4611 |
Rachel Lynn Flint, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4551 |
Justin Douglas Charlantini, MD General Practice Medicare: Medicare Enrolled Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 301-295-0156 |
Dr. Arjun Kalra, MD General Practice Medicare: Medicare Enrolled Practice Location: 4494 Palmer Rd N, Bethesda, MD 20814 Phone: 301-319-2100 Fax: 301-319-2119 |
Robert Spiller, General Practice Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-5035 Fax: 301-295-4599 |
Charleston Robert Powell, MD General Practice Medicare: Medicare Enrolled Practice Location: 4494 Palmer Rd N, Bethesda, MD 20814 Phone: 253-968-1110 |
Stephen Hunt Peacock, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Walter Reed National Military Medical Center, 4494 Palmer Rd N, Bethesda, MD 20814 Phone: 252-314-5200 |
Zachary Dace Brooks, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: Walter Reed National Military Medical Center, 4494 North Palmer Road, Bethesda, MD 20889 Phone: 301-295-4503 |
News Archive
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it has initiated a controlled two-arm Phase 2b clinical study of Azixa (verubulin) as a front-line treatment for glioblastoma multiforme (GBM).
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.
Mothers are viewed negatively if their child hasn't been vaccinated, no matter the reason. But mothers who outright refuse to vaccinate their children are viewed in a harsher light compared to those who delay vaccines because of safety concerns or who aren't up to date due to time constraints.
› Verified 4 days ago